Warfarin sodium and Armour thyroid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Warfarin sodium (warfarin sodium) and Armour thyroid (thyroid tablets, usp). Common drug interactions include facet joint syndrome among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Warfarin sodium and Armour thyroid. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Warfarin sodium?

Warfarin sodium has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 71,174 Warfarin sodium users. Check the latest studies of Warfarin sodium.

What is Armour thyroid?

Armour thyroid has active ingredients of thyroid tablets, usp. It is often used in hypothyroidism. eHealthMe is studying from 11,975 Armour thyroid users. Check the latest studies of Armour thyroid.



On Jul, 12, 2026

34 people who take Warfarin sodium and Armour thyroid together, and have interactions are studied.

Warfarin sodium and Armour thyroid drug interactions.

What are the common drug interactions of Warfarin Sodium and Armour Thyroid, by gender? *:

female:

  1. Facet joint syndrome (problem with movement of the facet joints of the spine)
  2. Fall
  3. Fatigue (feeling of tiredness)
  4. Forearm fracture (fracture in between wrist to elbow)
  5. Gait disturbance
  6. Gallbladder disorder
  7. Gangrene (body tissue dies)
  8. Gingival bleeding (bleeding gums)
  9. Gingival hyperplasia (overgrowth of gums)
  10. Gingival pain (gum pain)

male:

  1. Dizziness
  2. Lethargy (tiredness)
  3. Coagulopathy (blood's ability to clot is impaired)
  4. Confusional state
  5. Decreased appetite
  6. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  7. Diabetic ulcer
  8. Dyspnoea (difficult or laboured respiration)
  9. Enterococcus test positive
  10. Escherichia test positive

What are the common drug interactions of Warfarin Sodium and Armour Thyroid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Injury
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Thrombophlebitis superficial (swelling (inflammation) of a superficial vein caused by a blood clot)

40-49:

  1. Anaemia (lack of blood)
  2. Ascites (accumulation of fluid in the abdominal cavity)
  3. Asthenia (weakness)
  4. Bacterial sepsis
  5. Blindness
  6. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  7. Depression
  8. Drug ineffective
  9. Dyspnoea (difficult or laboured respiration)
  10. Gangrene (body tissue dies)

50-59:

  1. Gingival swelling (gums swelling)
  2. Gingivitis (inflammation of gums)
  3. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  4. Impaired healing
  5. Injury
  6. Intervertebral disc protrusion (spinal disc protrusion)
  7. Laryngeal oedema (swelling of larynx)
  8. Loss of consciousness
  9. Lumbar radiculopathy (radicular pain in the low back and legs)
  10. Lumbar spinal stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone)

60+:

  1. Dizziness
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Pain
  4. Prostatitis (inflammation of the prostate gland)
  5. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  6. Arteriovenous fistula thrombosis (formation of a blood clot inside a blood vessel-av fistula)
  7. Blood glucose increased
  8. Cardiac flutter (abnormal heart rhythm)
  9. Coagulopathy (blood's ability to clot is impaired)
  10. Confusional state

What are the existing conditions these people have? *

  1. Pain: 4 people, 11.76%
  2. Multiple Myeloma (cancer of the plasma cells): 3 people, 8.82%
  3. Fluid Retention (an abnormal accumulation of fluid in the blood): 3 people, 8.82%
  4. Constipation: 3 people, 8.82%
  5. Breast Cancer Female: 3 people, 8.82%
  6. Weight Increased: 2 people, 5.88%
  7. Thyroid Diseases: 2 people, 5.88%
  8. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 5.88%
  9. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 5.88%
  10. Combined Immunodeficiency: 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Warfarin sodium and Armour thyroid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Warfarin sodium and Armour thyroid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Warfarin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Armour thyroid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Warfarin sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Armour thyroid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on warfarin sodium and thyroid tablets, usp (the active ingredients of Warfarin sodium and Armour thyroid, respectively), and Warfarin sodium and Armour thyroid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: